期刊
PHARMACEUTICAL BIOLOGY
卷 59, 期 1, 页码 106-113出版社
TAYLOR & FRANCIS LTD
DOI: 10.1080/13880209.2020.1867197
关键词
Myocardial ischaemia; cardiac function; isoproterenol
资金
- National Natural Science Foundation of China [81473378]
- Natural Science Foundation of Jilin Province [20170101002JC]
- Jilin Scientific and Technological Development Program [20190103084JH]
The study showed that ginsenoside Rg2 can alleviate myocardial fibrosis and improve cardiac function in myocardial ischaemia rats, suggesting that ginsenosides may be promising agents for patients with myocardial ischaemia.
Context Panax ginseng C.A. Meyer (Araliaceae) has cardioprotective effects. Ginsenosides are responsible for most of the pharmacological activities of ginseng. Objective This study investigates the effect of ginsenoside Rg2 on myocardial fibrosis in myocardial ischaemia rats. Materials and methods Male Wistar rats were divided into control, isoproterenol, ginsenoside Rg2 (5, 20 mg/kg) groups (n = 8). The rats were subcutaneously injected with isoproterenol (5 mg/kg) or normal saline (control group) once daily for 7 days. The animals were intragastrically treated with ginsenoside Rg2 or 0.5% CMC-Na (control and isoproterenol groups) daily for 28 days. At day 28, cardiac function, myocardial fibrosis, and TGF-beta 1/Smad signalling pathway were evaluated. Results Compared with myocardial ischaemic rats, ginsenoside Rg2 at doses of 5, 20 mg/kg abated partially the augment of LVEDP (8.9 +/- 1.3 vs. 7.5 +/- 0.7, 7.2 +/- 1.0 mmHg) and the decreases of the LVSP (96.75 +/- 13.2 vs. 118.3 +/- 19.4, 124.3 +/- 21.3 mmHg), the + dp/dt (2142.8 +/- 309.3 vs. 2598.6 +/- 404.0, 2661.5 +/- 445.2 mmHg/s), and the -dp/dt (1996.3 +/- 306.3 vs. 2476.6 +/- 289.7, 2509.6 +/- 353.1 mmHg/s). Ginsenoside Rg2 (9.2 +/- 0.9%, 8.5 +/- 0.8%) alleviated myocardial fibrosis when compared with the isoproterenol group (10.1 +/- 1.0%), which was accompanied by suppressed TGF-beta 1/Smad signalling in heart tissues. Conclusions Ginsenosides from ginseng possess the property of alleviating myocardial fibrosis, improving cardiac function after myocardial ischaemia. Ginsenosides may be promising agents for improving the outcomes of patients with myocardial ischaemia.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据